2023-03-29
The city of Guangzhou welcomes Singapore Prime Minister Lee Hsien Loong, the first stop of his week-...
News
BioSyngen is developing multiple T-cell immunotherapies with the aim to address a wide range of malignancies.
2023-03-29
The city of Guangzhou welcomes Singapore Prime Minister Lee Hsien Loong, the first stop of his week-...
2022-05-28
SINGAPORE, Sept. 28, 2022 /PRNewswire/ — On September 22nd, Biosyngen signed to set up a Cell Therapy GMP Facility which will serve as a bas
2022-01-15
SINGAPORE, Sept. 28, 2022 /PRNewswire/ — On September 22nd, Biosyngen signed to set up a Cell Therapy GMP Facility which will serve as a bas
2021-12-29
SINGAPORE, Sept. 28, 2022 /PRNewswire/ — On September 22nd, Biosyngen signed to set up a Cell Therapy GMP Facility which will serve as a bas
2021-10-20
Singapore-based biotech firm Biosyngen has set its sights on developing these cell therapies to benefit an even larger group of cancer patients. PHOTO: BIOSYNGEN
2021-10-21
SINGAPORE, Sept. 28, 2022 /PRNewswire/ — On September 22nd, Biosyngen signed to set up a Cell Therapy GMP Facility which will serve as a bas
Copyright © 2022
Biosyngen Pte. Ltd.
Copyright © 2022 Biosyngen Pte. Ltd.
MENU